Heart Attack clinical trials

Explore recruiting heart attack clinical trials.

Recruiting heart attack studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Heart Attack trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pulse Glucocorticoid Therapy In Patients With ST-Segment Elevation Myocardial Infarction (PULSE-MI)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Prehospital pulse-dose glucocorticoid in patients with STEMI – the PULSE-MI 2 trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 prospective, blinded, randomized, placebo controlled, international multicenter study to assess the safety and efficacy of a single subcutaneous injection of zalunfiban in subjects with ST-elevation myocardial infarction in the pre-hospital setting

Netherlands, Romania, Czechia, France, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomised study for double-blind, placebo-controlled evaluation of BI 765845 on top of standard of care in patients with myocardial infarction

Slovakia, Poland, Germany, Czechia, Hungary, Italy +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of beta-blockers on how you feel and recover after a heart attack when your heart is still pumping well

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

ARTEMIS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction.

Greece, Bulgaria, Germany, Poland, Netherlands, Italy +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Heart Attack trials by city

Heart Attack in Toronto Heart Attack in Vancouver Heart Attack in Montreal Heart Attack in Calgary Heart Attack in Edmonton Heart Attack in Ottawa Heart Attack in Winnipeg Heart Attack in Quebec City Heart Attack in Hamilton Heart Attack in Kitchener Heart Attack in London Heart Attack in Halifax Heart Attack in New York Heart Attack in Los Angeles Heart Attack in Chicago Heart Attack in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease